Literature DB >> 8247322

Bacterial collagenase disrupts extracellular matrix and opens blood-brain barrier in rat.

G A Rosenberg1, E Estrada, R O Kelley, M Kornfeld.   

Abstract

Bacterial collagenase causes hemorrhagic necrosis of brain. We studied the enzyme's effect on blood-brain barrier (BBB) permeability and extracellular matrix (ECM) structure by radiolabeled tracers and electron microscopy. Adult rats had intracerebral injection of bacterial collagenase. Brain uptake from blood of [14C]sucrose was measured in 24 rats 0.5 h to 14 days after injection. 12 rats had ultrastructural studies 1 h after collagenase injection. Brain uptake of [14C]sucrose is maximally increased at 0.5 h, remaining significantly increased for 7 days. Ultrastructurally, some vessels had widening of basal lamina while others had severe disruption of basal lamina with stretching of endothelial cells. We conclude that bacterial collagenase disrupts ECM and opens BBB.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8247322     DOI: 10.1016/0304-3940(93)90927-d

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  32 in total

1.  Vascular adhesion protein-1 inhibition provides antiinflammatory protection after an intracerebral hemorrhagic stroke in mice.

Authors:  Qingyi Ma; Anatol Manaenko; Nikan H Khatibi; Wanqiu Chen; John H Zhang; Jiping Tang
Journal:  J Cereb Blood Flow Metab       Date:  2010-09-29       Impact factor: 6.200

Review 2.  Bacterial collagenases and collagen-degrading enzymes and their potential role in human disease.

Authors:  D J Harrington
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

3.  Irradiation alters MMP-2/TIMP-2 system and collagen type IV degradation in brain.

Authors:  Won Hee Lee; Junie P Warrington; William E Sonntag; Yong Woo Lee
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-04-01       Impact factor: 7.038

Review 4.  Comparison of different preclinical models of intracerebral hemorrhage.

Authors:  Anatol Manaenko; Hank Chen; John H Zhang; Jiping Tang
Journal:  Acta Neurochir Suppl       Date:  2011

5.  Matrix metalloproteinase 2 (MMP-2) degrades soluble vasculotropic amyloid-beta E22Q and L34V mutants, delaying their toxicity for human brain microvascular endothelial cells.

Authors:  Mar Hernandez-Guillamon; Stephanie Mawhirt; Silvia Fossati; Steven Blais; Mireia Pares; Anna Penalba; Merce Boada; Pierre-Olivier Couraud; Thomas A Neubert; Joan Montaner; Jorge Ghiso; Agueda Rostagno
Journal:  J Biol Chem       Date:  2010-06-24       Impact factor: 5.157

6.  Mononuclear phagocyte differentiation, activation, and viral infection regulate matrix metalloproteinase expression: implications for human immunodeficiency virus type 1-associated dementia.

Authors:  A Ghorpade; R Persidskaia; R Suryadevara; M Che; X J Liu; Y Persidsky; H E Gendelman
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

7.  Sequential Amyloid-β Degradation by the Matrix Metalloproteases MMP-2 and MMP-9.

Authors:  Mar Hernandez-Guillamon; Stephanie Mawhirt; Steven Blais; Joan Montaner; Thomas A Neubert; Agueda Rostagno; Jorge Ghiso
Journal:  J Biol Chem       Date:  2015-04-20       Impact factor: 5.157

Review 8.  Functions of the CB1 and CB 2 receptors in neuroprotection at the level of the blood-brain barrier.

Authors:  Esmée Vendel; Elizabeth C M de Lange
Journal:  Neuromolecular Med       Date:  2014-06-15       Impact factor: 3.843

9.  Chondroitinase ABC I-mediated enhancement of oncolytic virus spread and antitumor efficacy.

Authors:  Nina Dmitrieva; Lianbo Yu; Mariano Viapiano; Timothy P Cripe; E Antonio Chiocca; Joseph C Glorioso; Balveen Kaur
Journal:  Clin Cancer Res       Date:  2010-12-21       Impact factor: 12.531

10.  Doxycycline treatment decreases morbidity and mortality of murine neurocysticercosis: evidence for reduction of apoptosis and matrix metalloproteinase activity.

Authors:  Jorge I Alvarez; Janani Krishnamurthy; Judy M Teale
Journal:  Am J Pathol       Date:  2009-07-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.